Chronic Cough “Comes of Age”: A Landmark Shift in Respiratory Medicine at the Inaugural ERS Cough Conference on July 29, 2026 Posted by
The Sentinel’s Role: Navigating Bipolar Disorder Through the Lens of Friendship and Early Intervention on July 29, 2026 Posted by
Boston Scientific Faces Strategic Reset: Sales Guidance Slashed Amid Market Headwinds on July 29, 2026 Posted by
The Silent Epidemic: Confronting the Escalating Crisis of Healthcare Burnout on July 29, 2026 Posted by
Chronic Cough “Comes of Age”: A Landmark Shift in Respiratory Medicine at the Inaugural ERS Cough Conference on July 29, 2026 Posted by
The Sentinel’s Role: Navigating Bipolar Disorder Through the Lens of Friendship and Early Intervention on July 29, 2026 Posted by
Posted in Medical Innovations MapLight Therapeutics Faces Market Whiplash: Analyzing the Schizophrenia Drug Efficacy Gap on July 27, 2026
Posted in Digital Health Tools Crystalys Therapeutics Secures $130 Million to Propel Gout Drug Dotinurad Toward Market Entry on July 27, 2026
Posted in Digital Health Tools Beyond Chronic Care: Scribe Therapeutics Launches $128.7M IPO to Revolutionize Genetic Medicine on July 24, 2026
Posted in Medical Innovations Scribe Therapeutics Breaks Gene Editing IPO Drought with $129 Million Offering on July 24, 2026
Posted in Digital Health Tools Medtronic’s Strategic Pivot: Inside the $650 Million Acquisition of SPR Therapeutics on July 18, 2026
Posted in Medical Innovations Jasper Therapeutics Secures Financial Lifeline Through Strategic Merger with Kira Pharmaceuticals on July 17, 2026
Posted in Sleep Health New Frontiers in Neuropsychopharmacology: Addex Therapeutics’ Breakthrough in mGlu7 Receptor Modulation on July 15, 2026
Posted in Medical Innovations Avere Therapeutics Enters the Immunology Arena: A Strategic Pivot via Reverse Merger and Chinese Innovation on July 15, 2026
Posted in Cancer Recovery Pioneering Precision: Dr. Thomas Corner’s Quest to Redefine Lymphoma Therapeutics on July 11, 2026
Posted in Medical Innovations A New Era in Nephrology: FDA Grants Accelerated Approval to Vera Therapeutics’ Trutakna for IgA Nephropathy on July 9, 2026
